Skip to main content
. 1999 Nov;73(11):9650–9654. doi: 10.1128/jvi.73.11.9650-9654.1999

FIG. 4.

FIG. 4

Expression of the Vβ4 TCR on CD8+ T cells in the PBL population. Some of the γHV-68-infected (B6 × 129)F1 and CD40L−/− mice were treated from 2 days before virus challenge with successive doses of the GK1.5 MAb, a procedure that effectively eliminates the CD4+ subset (1). The experiment was done twice, with results of one representative experiment being shown. The results are means ± standard deviations for three or four individuals.